Website stats for Amicusrx - amicusrx.com
Committed to delivering meaningful benefits to the rare and orphan disease community, our dedicated leadership team is the driving force behind our developments. They are constantly inspired by others in the rare disease community, and continually aspire to reach new heights. We are a global biotechnology company at the forefront of advancing therapies for a range of rare and devastating diseases ...
amicusrx.com was registered 1 decade 6 years ago. It has a alexa rank of #1,057,413 in the world. It is a domain having .com extension. It is estimated worth of $ 1,200.00 and have a daily income of around $ 5.00. As no active threats were reported recently, amicusrx.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 829 |
| Daily Pageviews: | 1,658 |
Estimated Valuation
| Income Per Day: | $ 5.00 |
| Estimated Worth: | $ 1,200.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,057,413 |
| PageSpeed Score: | 29 ON 100 |
| Domain Authority: |
47 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
98.129.229.246
Hosted Country:
US
Location Latitude:
42.7333Location Longitude:
-84.6378Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For amicusrx.com
Amicus Therapeutics | Advancing Therapies to Treat Rare ...
Mar 19, 2020 · Clinical study participants and their family members can bring specific questions to their respective study site staff, as well as to Amicus Patient &...
Michael A. Kelly - amicusrx.com
Michael A. Kelly has served as a member of the Board since December 2020. Mr. Kelly is a former senior executive of Amgen, Inc. and is currently acting as Founder & President of...
Career Center - Amicus Therapeutics
Working with Amicus provides numerous opportunities to be inventive and purposeful, and where bold thinking and collaboration are highly valued— and expected.
Amicus Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (609)662-200 Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare and...
Amicus Opens New Global Research and Gene Therapy Center ...
Mar 05, 2020 · For more information please visit the company’s website at www.amicusrx.com and follow on Twitter and LinkedIn. CONTACTS: Media: Christopher Byrne Executive...
Programme - Amicus Therapeutics GmbH
Amicus Therapeutics (Nasdaq:FOLD) ist ein Biotechnologie-Unternehmen. Es ist führend bei der Entwicklung neuartiger Therapien zur Behandlung verschiedener schwerer seltener...
Michael A. Kelly - amicusrx.com
Michael A. Kelly has served as a member of the Board since December 2020. Mr. Kelly is a former senior executive of Amgen, Inc. and is currently acting as Founder & President of...
Amicus Therapeutics | LinkedIn
Amicus Therapeutics Biotechnology Cranbury, NJ 22,014 followers Amicus Therapeutics is committed to changing the lives of people with life-threatening conditions.
Amicus Therapeutics Appoints Michael A. Kelly to its Board ...
2 days ago · For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn. CONTACT: Investors: Amicus …
Programme - Amicus Therapeutics GmbH
Amicus Therapeutics (Nasdaq:FOLD) ist ein Biotechnologie-Unternehmen. Es ist führend bei der Entwicklung neuartiger Therapien zur Behandlung verschiedener schwerer seltener...
Amicus Therapeutics - Crunchbase Company Profile & Funding
Sep 20, 2018 · Contact Email [email protected] Phone Number (609)662-200 Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of …
Amicus Therapeutics Inc - Company Profile and News ...
Amicus Therapeutics, Inc. is a global biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic...
Amicus Therapeutics to Present at the Evercore ISI 3rd ...
Nov 23, 2020 · [email protected] (609) 662-3809 Media: Amicus Therapeutics Diana Moore Head of Global Corporate Communications [email protected] (609) 662-5079. FOLD–G.
Amicus Therapeutics, Inc. (FOLD) Interactive Stock Chart ...
For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.CONTACT:Investors: Amicus Therapeutics Andrew Faughnan Director,...
Welcome to Amicus Assist
Learn about Amicus Assist, a free service for patients and families designed to provide assistance and support to help with access to Galafold.
GALAFOLD® GLA Mutation Search
This site uses cookies to deliver the best possible website experience. By continuing to use this site, you agree to the use of our cookies. Our cookies do not collect personal...
Amicus Therapeutics, Inc. (FOLD) Stock Price, News, Quote ...
For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.CONTACT:Investors: Amicus Therapeutics Andrew Faughnan...
Science Center — uCity Square’s 3675 Market Welcomes ...
For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn. CONTACT: Sara Pellegrino, 609-662-5044,...
Amicus Therapeutics to Present at the Credit Suisse 29th ...
Nov 02, 2020 · For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn. CONTACT: Investors: Amicus Therapeutics Andrew...
Amicus Therapeutics Announces Public Offering of Common ...
May 29, 2019 · [email protected] (609) 662-5044. Media: Amicus Therapeutics Marco Winkler Director, Corporate Communications [email protected] (609) …
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | 9 |
| H3 Headings: | 5 | H4 Headings: | 6 |
| H5 Headings: | 3 | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 5 | Total Images: | 12 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Amicus Therapeutics | 9 | 1.01 % | No |
| the rare | 6 | 0.673 % | No |
| at the | 6 | 0.673 % | No |
| 2019 Amicus | 5 | 0.561 % | No |
| the forefront | 5 | 0.561 % | No |
| rare and | 5 | 0.561 % | No |
| disease community | 5 | 0.561 % | No |
| forefront of | 5 | 0.561 % | No |
| We are | 4 | 0.449 % | No |
| US healthcare | 4 | 0.449 % | No |
| rare disease | 4 | 0.449 % | No |
| to be | 4 | 0.449 % | No |
| and orphan | 4 | 0.449 % | No |
| to have | 3 | 0.337 % | No |
| with Fabry | 3 | 0.337 % | No |
| Contact Us | 3 | 0.337 % | No |
| in the | 3 | 0.337 % | No |
| of developing | 3 | 0.337 % | No |
| therapies to | 3 | 0.337 % | No |
| Gene Therapy | 3 | 0.337 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| at the forefront of | 5 | 0.561 % | No |
| the rare disease community | 4 | 0.449 % | No |
| rare and orphan diseases | 3 | 0.337 % | No |
| devastating rare and orphan | 3 | 0.337 % | No |
| a US healthcare professional | 3 | 0.337 % | No |
| developing therapies to potentially | 2 | 0.224 % | No |
| therapies to potentially address | 2 | 0.224 % | No |
| to potentially address significant | 2 | 0.224 % | No |
| of developing therapies to | 2 | 0.224 % | No |
| the forefront of developing | 2 | 0.224 % | No |
| potentially address significant unmet | 2 | 0.224 % | No |
| US healthcare professional I | 2 | 0.224 % | No |
| biotechnology company at the | 2 | 0.224 % | No |
| company at the forefront | 2 | 0.224 % | No |
| significant unmet needs for | 2 | 0.224 % | No |
| to the rare disease | 2 | 0.224 % | No |
| Therapy Development and Manufacturing | 2 | 0.224 % | No |
| us at the forefront | 2 | 0.224 % | No |
| as we work to | 2 | 0.224 % | No |
| A Rare Company – | 2 | 0.224 % | No |
Websites Hosted on Same IP (i.e. 98.129.229.246)
Six Point Harness – Animation Studio
Los Angeles studio specializing in top-shelf animation for broadcast, film, and web. Original development and production of animated shorts, series, and feature
4,719,659 
$ 240.00
Haymarket – A specialist international media company – Haymarket
218,182 $ 42,660.00
Ismaili-Based Personal & Business Banking - Texas | Nizari Credit...
Nizari Credit Union is an Ismaili-based credit union offering Personal and Business Banking services. With locations in Sugar Land, Dallas, and Austin, Texas, stop by a branch...
8,380,933 $ 240.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Server: Apache/2.4
Content-Type: text/html; charset=UTF-8
Date: Fri, 01 Nov 2019 19:38:56 GMT
Link:
Transfer-Encoding: chunked
Access-Control-Allow-Origin: *
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 2007-12-22 1 decade 6 years 10 months ago |
| Last Modified: | 2017-11-05 7 years 1 week 6 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns19.domaincontrol.com | |
97.74.109.10 | United States |
| ns20.domaincontrol.com | |
173.201.77.10 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| amicusrx.com | A | 572 |
IP: 98.129.229.246 |
| amicusrx.com | NS | 3600 |
Target: ns20.domaincontrol.com |
| amicusrx.com | NS | 3600 |
Target: ns19.domaincontrol.com |
| amicusrx.com | SOA | 3600 |
MNAME: ns19.domaincontrol.com RNAME: dns.jomax.net Serial: 2019081300 Refresh: 28800 Retry: 7200 Expire: 604800 |
| amicusrx.com | MX | 1800 |
Target: us-smtp-inbound-1.mimecast.com |
| amicusrx.com | MX | 1800 |
Priority: 1 Target: us-smtp-inbound-2.mimecast.com |
| amicusrx.com | TXT | 3600 |
TXT: docusign=9af354fb-3e1f-4327-bd78-c8c764e ced00 |
| amicusrx.com | TXT | 3600 |
TXT: adobe-idp-site-verification=f886eddc8613 b3e71e1b2ef90cb6761ebfa1d868840e458f85b4 e734c0660353 |
| amicusrx.com | TXT | 3600 |
TXT: v=spf1 include:spf.protection.outlook.com a:107-0-222-210-ip-static.hfc.comcastbus iness.net include:_netblocks.mimecast.com include:_spf.salesforce.com include:amazonses.com -all |
| amicusrx.com | TXT | 3600 |
TXT: +H3eq5TH2Dh0xqVqC7TCPzCk9rdaRuGD8EHtxaLx kPGhcyebbnt03+dtNANGxGCmuiRRzOW/WXH/6pHS huyypA== |
Full WHOIS Lookup
Registry Domain ID:
1360144953_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2017-11-05T10:58:25Z
Creation Date:
2007-12-21T19:04:26Z
Registry Expiry Date:
2022-12-21T19:04:26Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS19.DOMAINCONTROL.COM
Name Server:
NS20.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-11-01T19:39:08Z
Similarly Ranked Websites
Microsoft Online Support - A complete solution for all Microsoft...
A complete solution for all Microsoft Office relates issues
1,057,439 $ 1,200.00
Free and Valid Discount Codes, Promo Codes & Vouchers Codes –...
VoucherSea is the first choice of coupon hunters, and we provide free and valid discount codes, promo codes of thousands of online stores.
1,057,445 $ 1,200.00